Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2023.v8.i08.pp01-17 registered

Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease

Resolves to https://www.jst.org.in/index.php/pub/article/view/774

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2023.v8.i08.pp01-17

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 7bb4650f4bb93952…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease (PrincipalTitle · en)

Published 2023-08-21

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 8 · issue 8 · pages 1–17

Agents

  • Priyadarshini Roy (author)
  • Longman Publishers (publisher)

Identifiers DOI 10.46243/jst.2023.v8.i08.pp01-17

Abstract · en

Introduction: Lipotoxicity is a consequence of hyperlipidemia, in which the accumulation of lipids and cholesterol in the arteries contributes to atherosclerosis and may damage vital organs, including the heart and kidneys, leading to cardiovascular and other systemic disorders. Methods: Fasting blood samples were collected and analyzed using an automated biochemistry analyzer to evaluate lipid profiles. The study included 101 participants distributed among groups with hypertension, diabetes, kidney disease, and liver disease, together with a control group without these conditions. At least 20 volunteers were included in each group, with participants ranging in age from 18 to 70 years. The collected data were statistically analyzed using the independent two-sample t-test. Results: Participants with hypertension and diabetes showed significantly higher mean levels of low-density lipoprotein, very-low-density lipoprotein, total cholesterol, and triglycerides compared with the control group (p < 0.05). Lipid levels were also significantly higher among participants with kidney disease than among controls (p < 0.05), while high-density lipoprotein levels did not differ significantly. Participants with liver disease exhibited significantly higher mean triglyceride and very-low-density lipoprotein levels compared with the control group (p < 0.05). High-density lipoprotein levels were significantly lower in individuals with liver disease at the 90% confidence level. Conclusion: The findings demonstrate an association between hyperlipidemia and hypertension, diabetes, liver disease, and renal disease. Elevated blood pressure and diabetes were also observed in a substantial proportion of participants with renal and hepatic dysfunction, highlighting the importance of lipid-profile assessment in individuals with these conditions.

Licence https://creativecommons.org/licenses/by/4.0/

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2023.v8.i08.pp01-17doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
author: Priyadarshini Roy
publisher: Longman Publishers
published: 2023-08-21
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 8 · no. 8 · pp. 1–17
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2024-02-16record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 37 references; 33 carry a DOI.

#ReferenceDOIHeld here
1ref1 Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens. 2010 Jul;19(4):393-402. doi: 10.1097/ MNH.0b013e32833aa4ac, PMID 2048961310.1097/mnh.0b013e32833aa4acnot held here
2ref2 Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011 Dec;13(6):544-52. doi: 10.1007/s11886-011- 0220-3, PMID 2196869610.1007/s11886-011-0220-3not held here
3ref3 Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1…10.1186/s12933-018-0762-4not held here
4ref4 Jiang ZG, Robson SC, Yao Z. Lipoprotein metabolism in non-alcoholic fatty liver disease. J Biomed Res. 2013 Jan;27(1):1-13. doi: 10.7555/ JBR.27.20120077, PMID 2355478810.7555/jbr.27.20120077not held here
5ref5 Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight lo…10.1186/s12902-022-00980-1not held here
6ref6 Przybyszewski EM, Targher G, Roden M, Corey KE. Nonalcoholic fatty liver disease and cardiovascular disease. Clin Liver Dis. 2021;17(1):19-22. doi: 10.1002/cld.1017, PMID 3355248110.1002/cld.1017not held here
7ref7 Choudhury D, Tuncel M, Levi M. Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol. 2009 Nov;29(6):610- 20. doi: 10.1016/j.semnephrol.2009.07.00…10.1016/j.semnephrol.2009.07.006not held here
8ref8 Tao M, Wang HP, Sun J, Tian J. Progress of research on dyslipidemia accompanied by nephrotic syndrome. Chronic Dis Transl Med. 2020 Sep;6(3):182-7. doi: 10.1016/j. cdtm.2020.03.00…10.1016/j.cdtm.2020.03.002not held here
9ref9 Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. La…10.1016/s0140-6736(13)60595-4not held here
10ref10 Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol. 2012;56(6):1299-304. d…10.1016/j.jhep.2011.12.030not held here
11ref11 Chen S, Cheng W. Relationship between lipid profiles and hypertension: A cross-sectional study of 62,957 Chinese adult males. Front Public Health. 2022; 10:895499. doi: 10.3389/ f…10.3389/fpubh.2022.895499not held here
12ref12 Bønaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromsø study. Circulation. 1991;83(4, Apr):1305-14. doi: 10.1161/01.CIR.83.4.1305, PM…10.1161/01.cir.83.4.1305not held here
13ref13 Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016 Mar…10.1161/jaha.115.003053not held here
15ref15 Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep. 2013 Feb;15(1):59- 70. doi: 10.1007/s11906-012-0323-2, PMID …10.1007/s11906-012-0323-2not held here
16ref16 Mänttäri M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension. 1995;26(4):670-5. doi: 10.1161/01.hyp.26.4.67…10.1161/01.hyp.26.4.670not held here
17ref17 Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):2…10.1046/j.1523-1755.2000.00165.xnot held here
18ref18 Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G et al. Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chroni…10.1016/j.jcte.2016.08.002not held here
19ref19 Zhang H, Shi S, Zhao XJ, Wang JK, Liu ZW, Liu FQ et al. Association between the lipid profile and renal dysfunction in the heart failure patients. Kidney Blood Press Res. 2019;44(…10.1159/000498834not held here
20ref20 Lapinleimu H, Viikari J, Jokinen E, Routi T, Salo P, Hollo O et al. Cholesterol measurement by reflotron dry chemistry in infants, children and adults. Scand J Clin Lab Invest. 19…10.3109/00365519409086511not held here
21ref21 Moestrup SK, Nielsen LB. Nielsen et al. The role of the kidney in lipid metabolism. Curr Opin Lipidol. Jun 2005;16(3):301-6. doi: 10.1097/01. mol.0000169350.45944.d4, PMID 1589139110.1097/01.mol.0000169350.45944.d4not held here
23ref23 Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595-601. doi: 10.1161/01.HYP.0000145180.38707.84, PMID 1545…10.1161/01.hyp.0000145180.38707.84not held here
24ref24 Wang T, Visentin M, Gerd A, Xianjun F, Wang Z, Zhibo G et al. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11(4),722:11040722. doi: 10.3390/nu10.3390/nu11040722not held here
25ref25 Bhowmik B, Siddiquee T, Omsland KT. Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population (Int J Environ Res Public Health.2018. …10.3390/ijerph15091944not held here
26ref26 Sadeghi E, Hosseini SM, Vossoughi M, Aminorroaya A, Amini M. Association of lipid profile with Type 2 diabetes in first-degree relatives: A 14-year follow-up study in Iran. Diabet…10.2147/dmso.s259697not held here
27ref27 Indu KC, Deo RK, Roka K, Singh P, Alam Z. Study of Lipid profile in patients with Diabetes Mellitus presenting at tertiary referral center in Nepal, MJSBH vol. Vol. 21(1, Jan-Jun)…10.3126/mjsbh.v21i1.41605not held here
28ref28 Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol. 2011 Nov;5(6):1572- 83. doi: 10.1177/193229681100500634, PM…10.1177/193229681100500634not held here
30ref30 Mengyang H, Ling Y, Lu Z, Liu Y, Gu P, Shao J et al. Contribution and interaction of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and trig…10.1111/jdi.12856not held here
31ref31 Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab. 2013 Aug;24(8). Published online May 27:391-7:391-7. doi: 10.1016/j. tem.20…10.1016/j.tem.2013.04.001not held here
33ref33 Mahaling DU, Basavaraj MM, Bika AJ. Comparison of lipid profile in different grades of nonalcoholic fatty liver disease diagnosed on ultrasound. Asian Pac J Trop Biomed. 2013;3(11…10.1016/s2221-1691(13)60177-xnot held here
34ref34 Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the Persian Guilan cohort study …10.4103/jfmpc.jfmpc_243_18not held here
35ref35 Kumari R, Kumar PS, Jana D. Dyslipidaemia in non-alcoholic fatty liver disease. IJSR. 2021:24- 5. doi: 10.36106/ijsr/973945010.36106/ijsr/9739450not held here
36ref36 Cuenza LR, Razon TLJ, Dayrit JC. Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients. J Car…10.15171/jcvtr.2017.14not held here
37ref37 Novakovic T, Mekic M, Smilic L, Smilic T, Inić-Kostic B, Jovicevic L et al. Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by n…10.5455/medarh.2014.68.22-26not held here

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 161 fields set · sha256 2b13025b9269…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
abstract.value: Introduction: Lipotoxicity is a consequence of hyperlipidemia, in which the accumulation of lipids and cholesterol in the arteries contributes to atherosclerosis and may damage vital organs, including the heart and kidneys, leading to cardiovascular and other systemic disorders. Methods: Fasting blood samples were collected and analyzed using an automated biochemistry analyzer to evaluate lipid profiles. The study included 101 participants distributed among groups with hypertension, diabetes, kidney disease, and liver disease, together with a control group without these conditions. At least 20 volunteers were included in each group, with participants ranging in age from 18 to 70 years. The collected data were statistically analyzed using the independent two-sample t-test. Results: Participants with hypertension and diabetes showed significantly higher mean levels of low-density lipoprotein, very-low-density lipoprotein, total cholesterol, and triglycerides compared with the control group (p &lt; 0.05). Lipid levels were also significantly higher among participants with kidney disease than among controls (p &lt; 0.05), while high-density lipoprotein levels did not differ significantly. Participants with liver disease exhibited significantly higher mean triglyceride and very-low-density lipoprotein levels compared with the control group (p &lt; 0.05). High-density lipoprotein levels were significantly lower in individuals with liver disease at the 90% confidence level. Conclusion: The findings demonstrate an association between hyperlipidemia and hypertension, diabetes, liver disease, and renal disease. Elevated blood pressure and diabetes were also observed in a substantial proportion of participants with renal and hepatic dysfunction, highlighting the importance of lipid-profile assessment in individuals with these conditions. → Introduction: Lipotoxicity is a consequence of hyperlipidemia, in which the accumulation of lipids and cholesterol in the arteries contributes to atherosclerosis and may damage vital organs, including the heart and kidneys, leading to cardiovascular and other systemic disorders. Methods: Fasting blood samples were collected and analyzed using an automated biochemistry analyzer to evaluate lipid profiles. The study included 101 participants distributed among groups with hypertension, diabetes, kidney disease, and liver disease, together with a control group without these conditions. At least 20 volunteers were included in each group, with participants ranging in age from 18 to 70 years. The collected data were statistically analyzed using the independent two-sample t-test. Results: Participants with hypertension and diabetes showed significantly higher mean levels of low-density lipoprotein, very-low-density lipoprotein, total cholesterol, and triglycerides compared with the control group (p < 0.05). Lipid levels were also significantly higher among participants with kidney disease than among controls (p < 0.05), while high-density lipoprotein levels did not differ significantly. Participants with liver disease exhibited significantly higher mean triglyceride and very-low-density lipoprotein levels compared with the control group (p < 0.05). High-density lipoprotein levels were significantly lower in individuals with liver disease at the 90% confidence level. Conclusion: The findings demonstrate an association between hyperlipidemia and hypertension, diabetes, liver disease, and renal disease. Elevated blood pressure and diabetes were also observed in a substantial proportion of participants with renal and hepatic dysfunction, highlighting the importance of lipid-profile assessment in individuals with these conditions.
container.titles.0.value: Journal of Science &amp; Technology → Journal of Science & Technology

Machine-readable: the history as JSON, with the full record after each change.

Changes made at Crossref through DOI Doctor

Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.

WhenWhat changedCrossrefFingerprint
11 Sep 2026, 05:24Address updated
from https://jst.org.in/index.php/pub/article/view/774/701 to https://www.jst.org.in/index.php/pub/article/view/774
● accepted by Crossref5d5633976bb7…
13 Sep 2026, 01:41Read back: the DOI resolves to the new address● confirmeddcd316a3522e…
06 Nov 2026, 13:49Metadata completed
the record's metadata
● waiting for Crossref's answerc0c8bb00bf02…
06 Nov 2026, 14:11Read back: Crossref's record shows it● confirmed134fbdbc288b…

4 entries · the last fingerprint 134fbdbc288b59260ed12dc41130c30d3e4a89ab02160089fd1d326030f075cb · the history as JSON, each entry with the fingerprint before it, to check them yourself.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp